Anteris Technologies Company Description

Anteris Technologies Ltd, a structural heart company, engages in the designing, developing, and commercializing medical devices.

The company’s lead product candidate is DurAVR, a transcatheter heart valve (THV) for the treatment of aortic stenosis.

It also offers ComASUR, a delivery system that provides controlled deployment and placement of the DurAVR THV with balloon-expandable delivery, which allow precise alignment of the heart’s native commissures to achieve ideal valve positioning; and ADAPT, a patented anti-calcification tissue technology.

The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020.

Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia.

Anteris Technologies Ltd

Country	Australia
Founded	1999
Industry	Medical Devices
Sector	Healthcare
CEO	Wayne Paterson

Contact Details

Address: Toowong Tower Toowong, 4066 Australia
Phone	61 13 0055 0310
Website	anteristech.com

Stock Details

Ticker Symbol	AVR
Exchange	Australian Securities Exchange
Fiscal Year	January - December
Reporting Currency	AUD
ISIN Number	AU0000088841
SIC Code	3842

Key Executives

Name	Position
Wayne Geoffrey Paterson	Chief Executive Officer, MD and Executive Director
Matthew McDonnell	Chief Financial Officer
David St. Denis	Chief Operating Officer
Stephen Denaro	Independent Non-Executive Director and Company Secretary
Dr. Chris Meduri M.D., M.P.H.	Chief Medical Officer and Member of Medical Advisory Board